Brawn Biotech Limited reported unaudited standalone earnings for the first quarter ended June 30, 2018. For the quarter, the company reported revenue from operations of INR 135.619 million compared to INR 109.434 million a year ago. Total revenue was INR 136.231 million compared to INR 111.028 million a year ago. Profit from operation before other income, exceptional and extra-ordinary items was INR 5.313 million compared to INR 2.550 million a year ago. Profit from ordinary activities before tax was INR 5.313 million compared to INR 2.550 million a year ago. Profit for the period was INR 3.729 million compared to INR 1.678 million a year ago. Basic and diluted earnings per share were INR 1.37 compared to INR 0.56 a year ago.